Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Protein biomarker analysis of primary Peyronie's disease cells.

De Young LX, Bella AJ, O'Gorman DB, Gan BS, Lim KB, Brock GB.

J Sex Med. 2010 Jan;7(1 Pt 1):99-106. doi: 10.1111/j.1743-6109.2009.01556.x. Epub 2009 Nov 3.

PMID:
19889147
2.

Is there a role for proteomics in Peyronie's disease?

Domes T, De Young L, O'Gorman DB, Gan BS, Bella AJ, Brock G.

J Sex Med. 2007 Jul;4(4 Pt 1):867-77. Epub 2007 Apr 6. Review.

PMID:
17419813
3.

A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.

Jung KH, Ryu YL, Lee HS, Lee H, Son MK, Yan HH, Hong SW, Ryu JK, Hong S, Suh JK, Hong SS.

Int J Oncol. 2013 Jun;42(6):2001-8. doi: 10.3892/ijo.2013.1905. Epub 2013 Apr 16.

PMID:
23588860
4.

Comparison of apoptotic gene expression profiles between Peyronie's disease plaque and tunica albuginea.

Zorba OU, Sirma S, Ozgon G, Salabas E, Ozbek U, Kadioglu A.

Adv Clin Exp Med. 2012 Sep-Oct;21(5):607-14.

5.

Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.

Piao S, Choi MJ, Tumurbaatar M, Kim WJ, Jin HR, Shin SH, Tuvshintur B, Yin GN, Song JS, Kwon MH, Lee SJ, Han JY, Kim SJ, Ryu JK, Suh JK.

J Sex Med. 2010 Oct;7(10):3385-95. doi: 10.1111/j.1743-6109.2010.01753.x.

PMID:
20233292
6.

Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model.

Vernet D, Ferrini MG, Valente EG, Magee TR, Bou-Gharios G, Rajfer J, Gonzalez-Cadavid NF.

Nitric Oxide. 2002 Dec;7(4):262-76.

PMID:
12446175
7.

Profibrotic role of myostatin in Peyronie's disease.

Cantini LP, Ferrini MG, Vernet D, Magee TR, Qian A, Gelfand RA, Rajfer J, Gonzalez-Cadavid NF.

J Sex Med. 2008 Jul;5(7):1607-22. doi: 10.1111/j.1743-6109.2008.00847.x.

PMID:
18422491
8.

Identification of potential biomarkers of Peyronie's disease.

Lin GT, Wang Z, Liu BC, Lue TF, Lin CS.

Asian J Androl. 2005 Sep;7(3):237-43.

9.

Effect of SMAD7 gene overexpression on TGF-β1-induced profibrotic responses in fibroblasts derived from Peyronie's plaque.

Choi MJ, Song KM, Park JM, Kwon MH, Kwon KD, Park SH, Ryu DS, Ryu JK, Suh JK.

Asian J Androl. 2015 May-Jun;17(3):487-92. doi: 10.4103/1008-682X.142130.

10.

Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease.

Vernet D, Nolazco G, Cantini L, Magee TR, Qian A, Rajfer J, Gonzalez-Cadavid NF.

Biol Reprod. 2005 Dec;73(6):1199-210. Epub 2005 Aug 10.

PMID:
16093362
11.

Basic fibroblast growth factor expression in Peyronie's disease.

Mulhall JP, Thom J, Lubrano T, Shankey TV.

J Urol. 2001 Feb;165(2):419-23.

PMID:
11176387
12.

Inhibition of histone deacetylase 2 mitigates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.

Ryu JK, Kim WJ, Choi MJ, Park JM, Song KM, Kwon MH, Das ND, Kwon KD, Batbold D, Yin GN, Suh JK.

Asian J Androl. 2013 Sep;15(5):640-5. doi: 10.1038/aja.2013.61. Epub 2013 Jun 17.

13.

[Gene expression profiles and effects of transforming growth factor-beta1 intervention in Peyronie's disease].

Wang Z, Liu JF, Zhou ZH, Zhang YF, Wang WJ, Zhang P, Selcuk Y, Guiting L, Lin CS.

Zhonghua Wai Ke Za Zhi. 2004 Feb 7;42(3):182-6. Chinese.

PMID:
15062068
14.

Perturbation of cell cycle regulators in Peyronie's disease.

Mulhall JP, Branch J, Lubrano T, Shankey TV.

Int J Impot Res. 2001 Dec;13 Suppl 5:S21-8.

15.

Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.

Qian A, Meals RA, Rajfer J, Gonzalez-Cadavid NF.

Urology. 2004 Aug;64(2):399-404.

PMID:
15302515
16.
17.

Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse model.

Mulhall JP, Martin DJ, Lubrano T, Moser M, Kwon E, Wojcik E, Shankey TV.

Int J Impot Res. 2004 Apr;16(2):99-104.

PMID:
14973530
18.

Peyronie's disease and mechanotransduction: an in vitro analysis of the cellular changes to Peyronie's disease in a cell-culture strain system.

Chung E, De Young L, Solomon M, Brock GB.

J Sex Med. 2013 May;10(5):1259-67. doi: 10.1111/jsm.12082. Epub 2013 Feb 19.

PMID:
23421851
19.

Radiation increases fibrogenic cytokine expression by Peyronie's disease fibroblasts.

Mulhall JP, Branch J, Lubrano T, Shankey TV.

J Urol. 2003 Jul;170(1):281-4.

PMID:
12796706
20.

Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease.

Haag SM, Hauck EW, Szardening-Kirchner C, Diemer T, Cha ES, Weidner W, Eickelberg O.

Eur Urol. 2007 Jan;51(1):255-61. Epub 2006 May 19.

PMID:
16782264

Supplemental Content

Support Center